The debate over banning or legalizing marijuana has been going on for more than a century now, however it remains a fresh issue on the table. You can find people who strongly support its legalization, while there are lots of who vehemently oppose it. However, during the last decade, the debate has been tilted and only cannabis as the term “medical marijuana” has gained momentum with the aid of legalization campaigns. Still, you can find others who are preventing it from going everything legal.
The findings of a current study also go and only optimum medical utilization of marijuana. It says that a certain chemical found in marijuana can in fact aid in treating patients with drug-resistant types of epilepsy. This new study has provided evidence that marijuana can be effective in treatment for one-third of epilepsy patients who’ve a treatment-resistant form of the disease.
The analysis titled “Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial” – published in The Lancet Neurology – says that almost one-third of epilepsy patients are treatment-resistant and are related to severe morbidity and increased mortality. Though marijuana-based treatments for epilepsy have spiked the interest of individuals, scientific data about them is very limited, have the authors.
“We aimed to ascertain whether addition of cannabidiol to existing anti-epileptic regimens will be safe, tolerated, and efficacious in children and adults with treatment-resistant epilepsy,” the researchers said.
The researchers, led by Orrin Devinsky, neurologist at New York University Langone Medical Center, administered an extract of 99 percent cannabidiol (CBD) – a non-psychoactive chemical in marijuana – to 162 patients and monitored them for about 12 weeks. When is the best time to eat CBD gummies? The chemical was presented with as a product or add-on as well as other preexisting medicines of the patients and was conducted on an open level, which means individuals were alert to what they certainly were given. The researchers observed this intervention managed to cut back to motor seizures at the same rate by the present drugs, but 2 percent of patients became completely seizure free.
Despite some excellent results being shown by this process, the researchers feel that there surely is importance of further extensive studies on the subject. “Our findings suggest that cannabidiol might reduce seizure frequency and might have an adequate safety profile in children and adults with highly treatment-resistant epilepsy. Randomized controlled trials are warranted to characterize the safety profile and true efficacy with this compound,” the study said.
This is simply not the very first time when this observation has been made. Some previous studies had also drawn similar conclusions. A 2007 study, titled “Marijuana: An Effective Antiepileptic Treatment in Partial Epilepsy? A Case Report and Overview of the Literature,” published in the Reviews in Neurological Diseases had also stated that “marijuana or its active constituents might have a devote the treating partial epilepsy.”
Katherine Mortati, M.D., a neurologist at the Comprehensive Epilepsy Center at SUNY Downstate Medical Center, who had conducted the study, said “In the study we present the case of a 45-year-old man with cerebral palsy and epilepsy who showed marked improvement with the use of marijuana. This case supports other anecdotal data suggesting that marijuana use might be a beneficial adjunctive treatment in certain patients with epilepsy.”
Even The British Epilepsy Association had said in 2006 that “there’s scientific evidence to suggest that cannabis might be beneficial in treating numerous conditions, including epilepsy.”
More studies have to be done to get proof marijuana’s utility in working with epilepsy. Even when proved, marijuana will continue to be an addictive substance, that might have several unwanted effects, like hallucinations, cravings and drug seeking behavior.